GO:0036337 Fas signaling pathway: Apoptosis and Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036337 (Fas signaling pathway) describes the molecular cascade triggered when Fas ligand (FasL) binds the Fas receptor (CD95/Apo-1), a death domain-containing member of the TNFR superfamily.
• Fas signaling is best known for inducing extrinsic apoptosis via FADD and caspase-8, but it also activates non-apoptotic pathways such as NF-kB, MAPK, and PI3K, influencing proliferation, migration, and cytokine production.
• Dysregulated Fas/FasL signaling is implicated in autoimmune lymphoproliferative syndrome (ALPS), cancer immune evasion, osteosarcoma lung metastasis, recurrent spontaneous abortion, and toxicant-induced testicular apoptosis.
• The pathway is a therapeutic target: agonistic anti-Fas antibodies and FasL-based approaches are explored in oncology, while blocking Fas/FasL is considered for autoimmune and inflammatory conditions.
• Key genes include FAS, FASLG, FADD, CASP8, CASP10, and regulators such as CFLAR (c-FLIP), BID, and NF-kB components.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of Fas signaling in apoptosis, immune regulation, and disease.
Description
The Fas signaling pathway (GO:0036337) is a fundamental biological process that governs cell death and immune homeostasis. It is initiated by the binding of Fas ligand (FasL) to the Fas receptor (also known as CD95 or Apo-1), a death domain-containing member of the tumor necrosis factor receptor (TNFR) superfamily. This interaction triggers a cascade of molecular events that can lead to apoptosis, but also to non-apoptotic outcomes such as cell proliferation, differentiation, and cytokine secretion, depending on cellular context. Understanding this pathway is critical because its dysregulation contributes to a wide range of human diseases, including autoimmune disorders, cancer, and reproductive pathologies. Research on Fas signaling has revealed its dual role in health and disease. In the immune system, Fas-mediated apoptosis is essential for eliminating autoreactive lymphocytes and maintaining peripheral tolerance. In cancer, tumor cells often evade Fas-induced apoptosis, and the pathway can promote metastasis in certain contexts, such as osteosarcoma lung metastases. Moreover, environmental toxicants can trigger testicular cell apoptosis through Fas/FasL signaling, highlighting its role in reproductive toxicity. These diverse functions make Fas signaling a prime target for therapeutic intervention and a focus of intense biomedical research. This article provides a comprehensive overview of GO:0036337, covering its definition, molecular mechanisms, key genes, disease associations, and state-of-the-art research methods. By integrating authoritative QuickGO data with verified PubMed literature, we aim to equip researchers with a publication-ready resource for studying Fas signaling in health and disease.
Fas signaling pathway At A Glance
| GO ID | GO:0036337 |
|---|---|
| GO term | Fas signaling pathway |
| Ontology | biological_process |
| Synonym | Apo-1 signaling pathway, CD95 signaling pathway, Fas-FasL signaling pathway, FAS ligand-Fas signaling pathway, FasL signaling pathway, Fas receptor signaling pathway, FasR signaling pathway |
| Major function | Induction of apoptosis and regulation of immune homeostasis, cell proliferation, and cytokine production |
| Key receptor | Fas (CD95/Apo-1), a death domain-containing TNFR superfamily member |
| Key ligand | Fas ligand (FasL/CD95L) |
| Major adaptor | FADD (Fas-associated death domain protein) |
| Downstream effectors | Caspase-8, caspase-10, caspase-3, BID, NF-kB, MAPK |
What Is GO:0036337?
The Fas signaling pathway (GO:0036337) is defined as the series of molecular signals initiated by the binding of a ligand to a Fas receptor on the cell surface, culminating in the regulation of downstream cellular processes such as transcription or apoptosis. Fas is a death domain-containing member of the TNFR superfamily, and its activation typically involves the formation of a death-inducing signaling complex (DISC) that recruits and activates caspase-8, leading to apoptosis. However, the pathway can also engage non-apoptotic signaling cascades, including NF-kB and MAPK, depending on the cellular context.
Why Is Fas signaling pathway Important in Cell Biology?
The Fas signaling pathway is critically important because it serves as a central regulator of apoptosis and immune system homeostasis. Defects in this pathway cause autoimmune lymphoproliferative syndrome (ALPS), characterized by accumulation of autoreactive lymphocytes. In cancer, Fas signaling can be hijacked by tumor cells to evade immune destruction or to promote metastasis, as seen in osteosarcoma. Furthermore, the pathway is involved in reproductive biology, where its activation in trophoblasts is associated with recurrent spontaneous abortion, and in toxicant-induced testicular apoptosis. Given its broad physiological and pathological roles, Fas signaling is a major focus for therapeutic development, with strategies aiming to either activate or inhibit the pathway depending on the disease context.
• Regulates apoptosis in immune cells, essential for peripheral tolerance and prevention of autoimmunity.
• Mutations in FAS, FASLG, or CASP10 cause autoimmune lymphoproliferative syndrome (ALPS).
• Promotes metastasis in osteosarcoma, particularly to the lungs, and is a therapeutic target.
• Activation in trophoblasts is linked to recurrent spontaneous abortion.
• Mediates environmental toxicant-induced testicular cell apoptosis.
• Plays a dual role in cancer: can induce tumor cell death or promote immune evasion and metastasis.
• Non-apoptotic Fas signaling activates NF-kB, MAPK, and PI3K pathways, influencing inflammation and proliferation.
• The pathway is a target for agonistic antibodies and FasL-based therapies in oncology.
• Fas signaling is involved in damage-associated molecular pattern (DAMP)-sensing receptor crosstalk.
• CRISPR-based models enable precise functional dissection of Fas pathway components in disease.
What Happens During Fas signaling pathway?
Ligand Binding and Receptor Trimerization
In simple terms: FasL binds to Fas on the cell surface, causing Fas molecules to cluster together.
The Fas signaling pathway is initiated when Fas ligand (FasL), a homotrimeric cytokine, binds to the extracellular domain of Fas receptor (CD95/Apo-1). This binding induces trimerization of Fas and conformational changes that expose intracellular death domains (DDs). Fas is a member of the TNFR superfamily and contains a cytoplasmic death domain essential for signal transduction. The ligand-receptor interaction is highly specific and is a key regulatory step in the pathway.
Formation of the Death-Inducing Signaling Complex (DISC)
In simple terms: The clustered Fas receptors recruit adaptor proteins to form a signaling platform called DISC.
Upon trimerization, the death domains of Fas recruit the adaptor protein FADD (Fas-associated death domain protein) via homotypic DD-DD interactions. FADD then recruits procaspase-8 (and procaspase-10 in humans) through death effector domain (DED) interactions, forming the death-inducing signaling complex (DISC). This complex is the central platform for caspase activation and represents a critical checkpoint in the pathway.
Caspase Activation and Apoptosis Induction
In simple terms: The DISC activates caspase-8, which then triggers a cascade of caspases that dismantle the cell.
Within the DISC, procaspase-8 molecules are brought into close proximity, leading to their auto-proteolytic activation. Active caspase-8 then cleaves and activates downstream effector caspases, such as caspase-3, caspase-6, and caspase-7, which execute apoptosis by cleaving cellular substrates. Additionally, caspase-8 cleaves the Bcl-2 family protein BID to tBID, which amplifies the apoptotic signal through the mitochondrial pathway, linking extrinsic and intrinsic apoptosis. This cascade results in characteristic morphological changes of apoptosis.
Non-Apoptotic Signaling Branches
In simple terms: Fas can also send signals that promote cell survival, proliferation, or inflammation instead of death.
Beyond apoptosis, Fas signaling can activate non-apoptotic pathways, including NF-kB, MAPK (ERK, JNK, p38), and PI3K/Akt, depending on the cellular context and the strength of the signal. These pathways can promote cell proliferation, differentiation, cytokine production, and migration. For example, Fas engagement can lead to NF-kB activation through the recruitment of RIP1 and TRAF2, which is important for inflammatory responses and immune regulation. The balance between apoptotic and non-apoptotic signaling is tightly regulated and influences disease outcomes.
Regulation by c-FLIP and Other Modulators
In simple terms: Proteins like c-FLIP can block caspase-8 activation, controlling whether the cell dies or survives.
The Fas signaling pathway is modulated by several regulatory proteins. Cellular FLICE-like inhibitory protein (c-FLIP) competes with procaspase-8 for binding to FADD, thereby inhibiting DISC formation and caspase-8 activation. Other regulators include Bcl-2 family proteins, IAPs (inhibitor of apoptosis proteins), and ubiquitin ligases that control the stability of pathway components. These modulators determine the sensitivity of cells to Fas-induced apoptosis and contribute to resistance mechanisms in cancer.
Key Genes Involved in GO:0036337 Fas signaling pathway
The following genes encode core components and regulators of the Fas signaling pathway, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FAS | Encodes Fas receptor (CD95/Apo-1), the initiator of the pathway | Mutations cause ALPS; target for cancer therapy |
| FASLG | Encodes Fas ligand, the ligand that activates Fas | Mutations linked to ALPS; involved in immune privilege and cancer |
| FADD | Adaptor protein that recruits caspase-8 to Fas | Essential for DISC formation; knockout blocks apoptosis |
| CASP8 | Initiator caspase activated at the DISC | Key effector of apoptosis; mutations affect immune function |
| CASP10 | Initiator caspase with role in DISC | Mutations associated with ALPS type II |
| CFLAR | Encodes c-FLIP, inhibitor of caspase-8 activation | Regulates sensitivity to Fas-induced apoptosis; overexpressed in tumors |
| BID | Pro-apoptotic Bcl-2 family member cleaved by caspase-8 | Links extrinsic and intrinsic apoptosis; knockout reduces apoptosis |
| BAX | Pro-apoptotic effector of mitochondrial pathway | Amplifies Fas-induced apoptosis; knockout delays cell death |
| BAK | Pro-apoptotic effector of mitochondrial pathway | Cooperates with BAX in apoptosis; double knockout blocks mitochondrial apoptosis |
| RIPK1 | Kinase involved in non-apoptotic Fas signaling and necrosis | Modulates NF-kB activation and cell death decisions |
| TRAF2 | E3 ubiquitin ligase that mediates NF-kB activation | Required for non-apoptotic Fas signaling |
| NFKB1 | Transcription factor subunit activated by Fas | Mediates inflammatory and survival gene expression |
| MAPK8 | JNK kinase involved in stress responses | Activated by Fas; contributes to apoptosis or survival |
| CASP3 | Executioner caspase that dismantles cells | Final effector of apoptosis; knockout blocks cell death |
| CASP7 | Executioner caspase | Amplifies apoptosis; redundant with caspase-3 |
| BIRC5 | Encodes survivin, an inhibitor of apoptosis | Modulates Fas-induced apoptosis; target in cancer |
| XIAP | Inhibitor of apoptosis protein | Inhibits caspases; regulates Fas sensitivity |
How Is Fas signaling pathway Regulated?
The Fas signaling pathway is tightly regulated at multiple levels. At the receptor level, Fas expression can be modulated by transcription factors such as p53 and NF-kB, and by epigenetic mechanisms. The decoy receptor DcR3 (TNFRSF6B) can sequester FasL, preventing Fas activation. Intracellularly, c-FLIP inhibits caspase-8 recruitment to the DISC, while Bcl-2 family proteins and IAPs control the mitochondrial amplification loop. Post-translational modifications, including ubiquitination and phosphorylation of DISC components, also regulate pathway activity. Additionally, crosstalk with other signaling pathways, such as those downstream of DAMP-sensing receptors, can influence Fas-mediated outcomes. In disease contexts, dysregulation of these control mechanisms contributes to autoimmunity, cancer progression, and metastasis.
Fas signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAS | Autoimmune lymphoproliferative syndrome (ALPS) | Fas knockout mouse; patient-derived iPSCs with FAS mutations |
| FASLG | ALPS and cancer immune evasion | Faslg knockout mouse; tumor cells overexpressing FasL |
| CASP10 | ALPS type II | Casp10 knockout mouse; cell lines with CASP10 mutations |
| FAS | Osteosarcoma lung metastasis | Xenograft models with Fas knockdown or overexpression |
| FAS/FASLG | Recurrent spontaneous abortion | Trophoblast cell lines with CRISPR knockout of FAS |
Autoimmune Lymphoproliferative Syndrome (ALPS)
ALPS is a rare inherited disorder characterized by defective Fas-mediated apoptosis, leading to accumulation of autoreactive lymphocytes and lymphoproliferation. Most ALPS cases are caused by mutations in FAS, with fewer in FASLG or CASP10. The inability to eliminate self-reactive lymphocytes results in autoimmune cytopenias, lymphadenopathy, and splenomegaly. Diagnosis relies on detecting increased double-negative T cells and identifying mutations in the Fas pathway. Research using CRISPR knockout models of FAS or FASLG has been instrumental in understanding ALPS pathogenesis.
Cancer and Metastasis
Fas signaling plays a dual role in cancer. In some tumors, Fas-mediated apoptosis is a barrier to oncogenesis, but cancer cells often develop resistance by downregulating Fas, overexpressing c-FLIP, or secreting decoy receptors. Conversely, Fas/FasL signaling can promote tumor progression by inducing apoptosis of immune cells (immune evasion) and by stimulating migration and invasion. In osteosarcoma, Fas/FasL signaling in the lung microenvironment promotes metastasis, and targeting this pathway reduces lung metastases in preclinical models. These findings highlight the context-dependent nature of Fas signaling in cancer.
Reproductive Disorders
Fas/FasL signaling is implicated in recurrent spontaneous abortion. Activation of the pathway in trophoblasts can induce apoptosis, contributing to pregnancy loss. Studies have shown that increased Fas and FasL expression in trophoblastic cells correlates with miscarriage, suggesting that dysregulated apoptosis at the maternal-fetal interface is pathogenic. Additionally, environmental toxicants can trigger testicular cell apoptosis through Fas/FasL signaling, leading to male reproductive dysfunction. These findings underscore the importance of Fas signaling in reproductive health.
Inflammation and DAMP Sensing
Fas signaling intersects with damage-associated molecular pattern (DAMP)-sensing receptors, which are activated by cellular stress or injury. This crosstalk can amplify inflammatory responses and modulate cell death decisions. For example, DAMP-sensing receptors can upregulate Fas expression or sensitize cells to Fas-induced apoptosis, linking tissue damage to immune activation. Understanding these interactions may provide new therapeutic opportunities for inflammatory diseases.
From Fas signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FAS abolish Fas-induced apoptosis? | FAS knockout cell lines (e.g., HeLa, Jurkat) generated by CRISPR |
| How do point mutations in FAS death domain affect DISC formation? | Knock-in of patient-derived FAS mutations in cell lines |
| Can a tagged Fas receptor reveal real-time DISC dynamics? | Knock-in of fluorescent protein tag (e.g., GFP) at endogenous FAS locus |
| Does overexpression of c-FLIP confer resistance to Fas-mediated apoptosis? | Stable overexpression of CFLAR in cancer cell lines |
| What is the role of Fas signaling in osteosarcoma metastasis? | Fas knockout or overexpression in osteosarcoma cells followed by lung metastasis assays |
| Can CRISPR screening identify novel regulators of Fas-induced apoptosis? | Genome-wide CRISPR knockout library screening in Fas-sensitive cells |
How to Study the Fas signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI flow cytometry | Apoptosis and cell viability | Quantifying Fas-induced cell death |
| Caspase activity assay | Caspase-8/3/7 enzymatic activity | Monitoring DISC-mediated caspase activation |
| Co-immunoprecipitation | Protein-protein interactions in DISC | Detecting FADD-caspase-8 association |
| RNA-seq | Global transcriptional changes | Identifying NF-kB and p53 target genes |
| CRISPR knockout screening | Genes required for Fas-induced apoptosis | Discovering novel pathway regulators |
| Western blotting | Cleavage of caspase-8, BID, PARP | Confirming apoptosis activation |
| TUNEL staining | DNA fragmentation in situ | Detecting apoptosis in tissues |
| Mouse models (lpr/gld) | Autoimmunity and lymphoproliferation | Studying ALPS pathogenesis |
Apoptosis Assays
Apoptosis induced by Fas signaling is commonly measured using flow cytometry with Annexin V/propidium iodide staining, which detects phosphatidylserine externalization and membrane integrity. Caspase activity can be assessed using fluorogenic substrates or western blotting for cleaved caspase-8, caspase-3, and PARP. TUNEL staining detects DNA fragmentation in situ. These methods are essential for quantifying the functional outcome of Fas pathway activation.
Protein-Protein Interaction Studies
The formation of the DISC can be analyzed by immunoprecipitation of Fas or FADD followed by western blotting for caspase-8, c-FLIP, and other components. Co-immunoprecipitation and pull-down assays with recombinant death domains are used to map interactions. Advanced techniques such as proximity ligation assays and FRET can visualize DISC assembly in live cells. These approaches are critical for understanding pathway activation and regulation.
Transcriptional and Genomic Analysis
RNA sequencing (RNA-seq) can reveal global transcriptional changes downstream of Fas activation, including induction of NF-kB target genes and apoptotic regulators. Chromatin immunoprecipitation sequencing (ChIP-seq) identifies transcription factor binding sites for NF-kB and p53 in Fas-responsive genes. CRISPR screens combined with RNA-seq can uncover novel regulators of Fas signaling. These methods provide systems-level insights into the pathway.
In Vivo Models
Mouse models with targeted deletions of Fas (lpr) or Faslg (gld) are classic tools for studying ALPS and autoimmunity. Xenograft and syngeneic tumor models are used to investigate Fas signaling in cancer metastasis, particularly in osteosarcoma. Conditional knockout mice allow tissue-specific analysis of Fas function. These models are indispensable for translating in vitro findings to human disease.
How CRISPR Can Be Used to Study GO:0036337 Fas signaling pathway
Knockout
CRISPR/Cas9-mediated knockout of FAS, FASLG, FADD, or CASP8 is widely used to abrogate Fas signaling and study its role in apoptosis, immune regulation, and disease. For example, FAS knockout in Jurkat cells renders them resistant to Fas-induced apoptosis, confirming the receptor's essential function. Knockout of FADD or CASP8 blocks DISC formation and downstream caspase activation. In cancer research, knockout of FAS in osteosarcoma cells can reduce lung metastasis in xenograft models. These models are invaluable for target validation.
Point Mutation
CRISPR-based point mutations can mimic patient-derived mutations in FAS, FASLG, or CASP10 to study their functional consequences. For instance, knock-in of the ALPS-associated FAS mutation (e.g., Fas death domain mutations) in cell lines recapitulates defective apoptosis and provides a platform for drug testing. Point mutations in the caspase-8 catalytic domain can dissect its role in apoptosis versus non-apoptotic signaling. These models offer precise insights into disease mechanisms.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous FAS locus allows real-time visualization and biochemical analysis of the receptor. Tagged Fas can be used to track receptor trafficking, DISC assembly, and internalization. Knock-in of luciferase reporters downstream of Fas-responsive promoters enables in vivo imaging of pathway activity. These models are powerful for dynamic studies.
Overexpression
Overexpression of Fas, FasL, or c-FLIP using CRISPR activation (CRISPRa) or lentiviral vectors is used to study gain-of-function effects. Overexpression of c-FLIP confers resistance to Fas-induced apoptosis in cancer cells, modeling immune evasion. Conversely, overexpression of Fas sensitizes cells to apoptosis and can suppress tumor growth. These models help identify therapeutic strategies targeting the pathway.
How EDITGENE Supports Fas signaling pathway Research
Researchers studying Fas signaling pathway-related genes often need to determine whether a candidate gene is causally involved in apoptosis, immune regulation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for Fas signaling pathway research.
Frequently Asked Questions About Fas signaling pathway
What is the Fas signaling pathway?
The Fas signaling pathway (GO:0036337) is a biological process initiated by Fas ligand binding to the Fas receptor, leading to apoptosis or non-apoptotic signaling. It is essential for immune homeostasis and is implicated in autoimmune diseases and cancer.
What genes are involved in the Fas signaling pathway?
Key genes include FAS (receptor), FASLG (ligand), FADD (adaptor), CASP8 and CASP10 (initiator caspases), CFLAR (c-FLIP, inhibitor), and BID (amplifier). These genes are critical for pathway function and disease.
What diseases are associated with Fas signaling?
Fas signaling defects cause autoimmune lymphoproliferative syndrome (ALPS), and the pathway is involved in cancer metastasis, recurrent spontaneous abortion, and toxicant-induced testicular apoptosis.
How does Fas induce apoptosis?
Fas ligand binding triggers Fas trimerization and DISC formation, recruiting FADD and caspase-8. Caspase-8 activation leads to effector caspase activation and apoptosis.
What is the role of FADD in Fas signaling?
FADD is an adaptor protein that bridges Fas to caspase-8 via death domain and death effector domain interactions, forming the DISC and initiating apoptosis.
Can Fas signaling promote cell survival?
Yes, in certain contexts Fas can activate NF-kB, MAPK, and PI3K pathways, promoting survival, proliferation, or cytokine production instead of apoptosis.
How is Fas signaling studied in the lab?
Common methods include apoptosis assays (Annexin V, caspase activity), co-immunoprecipitation for DISC, RNA-seq, CRISPR knockout models, and mouse models like lpr/gld.
What is the role of c-FLIP in Fas signaling?
c-FLIP (encoded by CFLAR) inhibits caspase-8 activation at the DISC, thereby blocking Fas-induced apoptosis and contributing to resistance in cancer.
Is Fas signaling a target for cancer therapy?
Yes, both agonistic and antagonistic strategies are being developed. Agonistic anti-Fas antibodies aim to induce tumor cell apoptosis, while blocking Fas/FasL may prevent metastasis and immune evasion.
What CRISPR models are available for Fas signaling research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for FAS, FASLG, FADD, CASP8, and other pathway genes, as well as CRISPR library screening and bioinformatics services.
Conclusion
The Fas signaling pathway (GO:0036337) is a cornerstone of apoptosis and immune regulation, with profound implications for autoimmune diseases, cancer, and reproductive disorders. Its dual ability to induce cell death or promote survival depending on context makes it a challenging but rewarding research area. Advances in CRISPR-based models and high-throughput screening are accelerating our understanding of this pathway and enabling the development of targeted therapies. EDITGENE is committed to supporting this research with state-of-the-art gene editing services.
References
- 1. Galli G et al.. 2022. Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors.. Cells 11(9) PMID: 35563744
- 2. Koshkina N et al.. 2020. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.. Adv Exp Med Biol 1258:177-187 PMID: 32767242
- 3. Wajant H. 2002. The Fas signaling pathway: more than a paradigm.. Science 296(5573):1635-6 PMID: 12040174
- 4. Matson DR et al.. 2020. Autoimmune Lymphoproliferative Syndrome: An Overview.. Arch Pathol Lab Med 144(2):245-251 PMID: 30958694
- 5. Xu Q et al.. 2021. Effect of Fas/FasL signaling pathway activation in trophoblasts on recurrent spontaneous abortion.. J Obstet Gynaecol Res 47(6):1978-1986 PMID: 33723884
- 6. Huang G et al.. 2014. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.. Adv Exp Med Biol 804:203-17 PMID: 24924176
- 7. Wang M et al.. 2018. The role of the Fas/FasL signaling pathway in environmental toxicant-induced testicular cell apoptosis: An update.. Syst Biol Reprod Med 64(2):93-102 PMID: 29299971
- 8. Villa-Morales M et al.. 2012. Targeting the Fas/FasL signaling pathway in cancer therapy.. Expert Opin Ther Targets 16(1):85-101 PMID: 22239437
